Raquel Martinez
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque
Rotger M, Miró J, Palou E, Hoffmann M, Massanella M, Blanco J, Woods M, Günthard H, de Bakker P, Douek D, Silvestri G, Martinez-Picado J, Hirschel B, Fellay J, Erkizia I, Dalmau J, Rauch A, McLaren P, Bosinger S, Martinez R, Sandler N, Roque A, Liebner J, Battegay M, Bernasconi E, Descombes P, Telenti A. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest 2011; 121:2391-400.
May 9, 2011Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque
May 9, 2011J Clin Invest 2011; 121:2391-400
Rotger Margalida, Miró Jose M, Palou Eduard, Hoffmann Matthias, Massanella Marta, Blanco Julià, Woods Matthew, Günthard Huldrych F, de Bakker Paul, Douek Daniel C, Silvestri Guido, Martinez-Picado Javier, Hirschel Bernard, Fellay Jacques, Erkizia Itziar, Dalmau Judith, Rauch Andri, McLaren Paul, Bosinger Steven E, Martinez Raquel, Sandler Netanya G, Roque Annelys, Liebner Julia, Battegay Manuel, Bernasconi Enos, Descombes Patrick, Telenti Amalio
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance
di Iulio J, Rauch A, Telenti A, Klenerman P, Barnes E, Hirschel B, Schmid P, Bernasconi E, Battegay M, Günthard H, Furrer H, Pulit S, Martinez R, Fellay J, Rotger M, Kelleher D, Fitzmaurice K, Ciuffi A, Swiss HIV Cohort Study. Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology 2011; 53:1446-54.
May 1, 2011Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance
May 1, 2011Hepatology 2011; 53:1446-54
di Iulio Julia, Rauch Andri, Telenti Amalio, Klenerman Paul, Barnes Eleanor, Hirschel Bernard, Schmid Patrick, Bernasconi Enos, Battegay Manuel, Günthard Huldrych F, Furrer Hansjakob, Pulit Sara, Martinez Raquel, Fellay Jacques, Rotger Margalida, Kelleher Dermot, Fitzmaurice Karen, Ciuffi Angela, Swiss HIV Cohort Study
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy
Ortiz M, Tarr P, Telenti A, Günthard H, Ledergerber B, Cavassini M, Hirschel B, Vernazza P, Bernasconi E, Elzi L, Arnedo M, Martinez R, Kovari H, Furrer H, Poloni E, Swiss HIV Cohort Study. No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. J Infect Dis 2011; 203:620-4.
Jan 12, 2011No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy
Jan 12, 2011J Infect Dis 2011; 203:620-4
Ortiz Millán, Tarr Philip E, Telenti Amalio, Günthard Huldrych F, Ledergerber Bruno, Cavassini Matthias, Hirschel Bernard, Vernazza Pietro, Bernasconi Enos, Elzi Luigia, Arnedo Mireia, Martinez Raquel, Kovari Helen, Furrer Hansjakob, Poloni Estella S, Swiss HIV Cohort Study
Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
Lubomirov R, Telenti A, Günthard H, Furrer H, Vernazza P, Elzi L, Bernasconi E, Hirschel B, Cavassini M, Martinez R, Ledergerber B, di Iulio J, Colombo S, the Swiss HIV Cohort Study. Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study. J Infect Dis 2010; 203:246-257.
Dec 9, 2010Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study
Dec 9, 2010J Infect Dis 2010; 203:246-257
Lubomirov Rubin, Telenti Amalio, Günthard Huldrych F, Furrer Hansjakob, Vernazza Pietro, Elzi Luigia, Bernasconi Enos, Hirschel Bernard, Cavassini Matthias, Martinez Raquel, Ledergerber Bruno, di Iulio Julia, Colombo Sara, the Swiss HIV Cohort Study
Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals
Rotger M, Tarr P, Telenti A, Egger M, Ledergerber B, Weber R, Furrer H, Hirschel B, Bernasconi E, Cavassini M, Vernazza P, Elzi L, Taffé P, Martinez R, Gsponer T, Swiss HIV Cohort Study. Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals. Clin Infect Dis 2010; 51:1090-8.
Nov 1, 2010Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals
Nov 1, 2010Clin Infect Dis 2010; 51:1090-8
Rotger Margalida, Tarr Philip E, Telenti Amalio, Egger Matthias, Ledergerber Bruno, Weber Rainer, Furrer Hansjakob, Hirschel Bernard, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Elzi Luigia, Taffé Patrick, Martinez Raquel, Gsponer Thomas, Swiss HIV Cohort Study
Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.
Halter J, Schüpbach W, Casali C, Elhasid R, Fay K, Hammans S, Illa I, Kappeler L, Krähenbühl S, Lehmann T, Mandel H, Martinez R, Mattle H, Orchard K, Savage D, Sue C, Valcarcel D, Gratwohl A, Hirano M. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 2010; 46:330-337.
May 3, 2010Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach.
May 3, 2010Bone Marrow Transplant 2010; 46:330-337
Halter J, Schüpbach Wmm, Casali C, Elhasid R, Fay K, Hammans S, Illa I, Kappeler L, Krähenbühl S, Lehmann Thomas, Mandel H, Martinez Raquel, Mattle Heinrich P, Orchard K, Savage David B, Sue C M, Valcarcel D, Gratwohl A, Hirano M
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir
Lubomirov R, Telenti A, Csajka C, Decosterd L, Buclin T, Descombes P, Rentsch K, Ledergerber B, Cavassini M, Calmy A, Vernazza P, Furrer H, Marzolini C, Martinez R, Colombo S, Fayet A, di Iulio J, Swiss HIV Cohort Study. ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir. Pharmacogenet Genomics 2010; 20:217-30.
Apr 1, 2010ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir
Apr 1, 2010Pharmacogenet Genomics 2010; 20:217-30
Lubomirov Rubin, Telenti Amalio, Csajka Chantal, Decosterd Laurent A, Buclin Thierry, Descombes Patrick, Rentsch Katharina, Ledergerber Bruno, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Furrer Hansjakob, Marzolini Catia, Martinez Raquel, Colombo Sara, Fayet Aurélie, di Iulio Julia, Swiss HIV Cohort Study
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study
Rotger M, Tarr P, Telenti A, Ledergerber B, Weber R, Witteck A, Furrer H, Hirschel B, Battegay M, Bernasconi E, Cavassini M, Martinez R, Taffé P, Bayard C, Swiss HIV Cohort Study. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study. Circulation. Cardiovascular genetics 2009; 2:621-8.
Dec 1, 2009Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study
Dec 1, 2009Circulation. Cardiovascular genetics 2009; 2:621-8
Rotger Margalida, Tarr Philip E, Telenti Amalio, Ledergerber Bruno, Weber Rainer, Witteck Andrea, Furrer Hansjakob, Hirschel Bernard, Battegay Manuel, Bernasconi Enos, Cavassini Matthias, Martinez Raquel, Taffé Patrick, Bayard Cornelia, Swiss HIV Cohort Study
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders
Tarr P, Telenti A, Ledergerber B, Rickenbach M, Darioli R, Bernasconi E, Vernazza P, Weber R, Battegay M, Hirschel B, Martinez R, Rotger M, Furrer H, Bleiber G, Taffé P, Swiss HIV Cohort Study. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. The Journal of infectious diseases 2005; 191:1419-26.
May 1, 2005Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders
May 1, 2005The Journal of infectious diseases 2005; 191:1419-26
Tarr Philip E, Telenti Amalio, Ledergerber Bruno, Rickenbach Martin, Darioli Roger, Bernasconi Enos, Vernazza Pietro, Weber Rainer, Battegay Manuel, Hirschel Bernard, Martinez Raquel, Rotger Margalida, Furrer Hansjakob, Bleiber Gabriela, Taffé Patrick, Swiss HIV Cohort Study